tiprankstipranks
Jiutian Chemical Group Limited (SG:C8R)
SGX:C8R
Singapore Market

Jiutian Chemical Group Limited (C8R) AI Stock Analysis

Compare
8 Followers

Top Page

SG:C8R

Jiutian Chemical Group Limited

(SGX:C8R)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
S$0.02
▲(15.00% Upside)
Action:ReiteratedDate:03/26/26
The score is pressured primarily by sharply deteriorating financial performance (heavy losses, negative gross profit, and negative operating/free cash flow). Technicals are also soft with negative momentum and the price below longer-term moving averages. Valuation offers limited support due to negative earnings (negative P/E) and no available dividend yield.
Positive Factors
Balance sheet leverage
Moderate and improving leverage (debt-to-equity ~0.28) preserves financing flexibility despite operational losses. Lower relative debt reduces near-term refinancing and interest burden, making it easier to fund restructuring, working capital or targeted investments while management works to restore profitability.
Negative Factors
Material revenue decline
A multi-year, material revenue decline erodes scale and market presence, reducing bargaining power with suppliers and customers. Sustained top-line contraction makes it harder to cover fixed costs, lengthens recovery timelines, and implies the business needs new demand drivers or market wins to restore sustainable operations.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet leverage
Moderate and improving leverage (debt-to-equity ~0.28) preserves financing flexibility despite operational losses. Lower relative debt reduces near-term refinancing and interest burden, making it easier to fund restructuring, working capital or targeted investments while management works to restore profitability.
Read all positive factors

Jiutian Chemical Group Limited (C8R) vs. iShares MSCI Singapore ETF (EWS)

Jiutian Chemical Group Limited Business Overview & Revenue Model

Company Description
Jiutian Chemical Group Limited, an investment holding company, manufactures and sells chemical-based products in the People's Republic of China. The company offers dimethylformamide, which is used as a feedstock in the production of polyurethane, ...
How the Company Makes Money
null...

Jiutian Chemical Group Limited Financial Statement Overview

Summary
Overall fundamentals are weak: revenue declined materially in 2023–2025, profitability deteriorated to deeply negative margins (including negative gross profit), and 2025 ended with a large net loss. Cash flow is also negative (operating and free cash flow in 2023–2025), increasing funding pressure. The balance sheet is a partial offset with moderate and improving leverage (debt-to-equity ~0.28 in 2025), but repeated losses create ongoing risk to the equity base.
Income Statement
12
Very Negative
Balance Sheet
45
Neutral
Cash Flow
18
Very Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue393.13M106.22M243.76M598.56M2.43B2.17B
Gross Profit-147.20M-106.22M-82.26M-260.18M708.41M675.62M
EBITDA-141.98M-96.04M-118.22M-321.76M696.61M517.79M
Net Income-162.31M-165.01M-147.80M-344.64M490.50M324.90M
Balance Sheet
Total Assets1.42B699.69M1.05B1.29B1.99B1.89B
Cash, Cash Equivalents and Short-Term Investments698.48M198.16M400.41M529.62M1.11B773.55M
Total Debt234.88M127.62M289.32M265.88M134.64M228.18M
Total Liabilities469.16M248.45M427.02M523.23M764.65M1.08B
Stockholders Equity948.17M451.24M618.04M765.84M1.22B816.21M
Cash Flow
Free Cash Flow-356.18M-155.06M-171.63M-511.23M424.05M633.54M
Operating Cash Flow-328.39M-129.87M-81.58M-385.65M434.01M655.81M
Investing Cash Flow-27.72M-24.57M-89.54M-125.70M-9.85M-27.68M
Financing Cash Flow-53.04M-160.50M32.87M-732.00K-95.52M-110.89M

Jiutian Chemical Group Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Negative
200DMA
0.03
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
43.20
Neutral
STOCH
24.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C8R, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 43.20 is Neutral, neither overbought nor oversold. The STOCH value of 24.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:C8R.

Jiutian Chemical Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
52
Neutral
S$37.21M-0.87-19.55%0.92%-7.45%-480.22%
44
Neutral
S$43.75M-1.64-30.86%-2.43%52.80%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:C8R
Jiutian Chemical Group Limited
0.02
>-0.01
-18.52%
SG:C05
Chemical Industries Far East Ltd.
0.49
-0.01
-2.00%
SG:5DS
MegaChem Ltd.
0.43
0.04
11.84%
SG:A55
Asia Enterprises Holding Ltd.
0.15
0.02
15.08%
SG:BEI
LHT Holdings Ltd
1.10
0.10
10.00%
SG:Y8E
Samurai 2K Aerosol Ltd.
0.13
0.07
118.33%

Jiutian Chemical Group Limited Corporate Events

Jiutian Chemical Drops Synthetic Ammonia Investment Amid Tightening China Credit
Dec 29, 2025
Jiutian Chemical Group has mutually agreed with Anyang Chemical Industry Group to terminate its planned investment in a synthetic ammonia project and the lease of a urea production facility in China, after reassessing the project’s commercia...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 26, 2026